Pharma BD Deal Intelligence

Abbott Laboratories / Solvay Pharmaceuticals (Solvay Group)

2009 · Acquisition/Merger · $6.6B · Complete

Abbott Laboratories acquired Solvay Pharmaceuticals for EUR 5.2B (~$6.6B) plus up to ~$440M in milestones, adding fenofibrate (TriCor/Trilipix), a vaccines business, and emerging-markets presence; closed February 2010.

Key facts

• Announced Sep 28, 2009
• Deal value $6.6B
• Deal type Acquisition/Merger

← Browse all deals  ·  How we score deals